Jpmorgan Chase & CO SPYRE THERAPEUTICS INC Transaction History

Jpmorgan Chase & CO

  • $1.51 Trillion
  • Q3 2025
Number of Shares
275,984
Previous 41,556 564.13%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
BUY
N/A
234,428 Added 564.13%
275,984 $0
Q1 2025

May 12, 2025
BUY
N/A
6,308 Added 17.9%
41,556 $0
Q4 2024

Feb 12, 2025
BUY
N/A
5,775 Added 19.59%
35,248 $0
Q3 2024

Dec 26, 2024
BUY
N/A
6,701 Added 29.43%
29,473 $0
Q3 2024

Nov 08, 2024
BUY
N/A
6,701 Added 29.43%
29,473 $0
Q2 2024

Dec 26, 2024
SELL
N/A
-6,701 Reduced 22.74%
22,772 $0
Q2 2024

Aug 12, 2024
BUY
N/A
22,761 Added 206918.19%
22,772 $0
Q1 2024

Dec 26, 2024
SELL
N/A
-29,462 Reduced 99.96%
11 $0
Q1 2024

May 10, 2024
SELL
N/A
-30 Reduced 73.17%
11 $0
Q4 2023

Dec 26, 2024
SELL
N/A
-29,432 Reduced 99.86%
41 $0
Q3 2023

Nov 14, 2023
BUY
N/A
41 New
41 $0
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email